Chemed (CHE) Capital Expenditures (2009 - 2026)

Chemed has reported Capital Expenditures for 18 years, with the latest figure at $15.5 million in Q2 2026.

• Capital Expenditures for Q2 2026 came in at $15.5 million, down 1.8% year-over-year; the trailing twelve-month figure through Jun 2026 was $66.3 million (up 19.77% YoY), and the FY2025 annual result was $62.8 million, up 26.78% from the prior year.
• Capital Expenditures retreated to $15.5 million in Q2 2026, from $17.1 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $18.3 million in Q4 2022 and troughed at $11.1 million in Q2 2024.
• A 5-year average of $14.4 million and a median of $13.5 million in 2022 frame the typical range for Capital Expenditures.
• The widest annual swing landed in 2023, when Capital Expenditures tumbled 35.49%; it then surged 42.9% in 2025.
• A 5-year view of Capital Expenditures shows it stood at $18.3 million in 2022, then tumbled by 35.49% to $11.8 million in 2023, then gained by 8.34% to $12.8 million in 2024, then increased by 28.11% to $16.3 million in 2025, then slipped by 5.05% to $15.5 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $15.5 million in Q2 2026, $17.1 million in Q1 2026, and $16.3 million in Q4 2025.